MET and gastric cancer: To assess their potential deregulation in GC, we studied ARID1A, CDH1, cMET and PIK3CA expression levels in gastric adenocarcinoma comparing them with normal gastric mucosa, using quantitative real-time reverse transcription PCR (RT-qPCR) and immunohistochemistry (IHC).